128 related articles for article (PubMed ID: 1509106)
1. Asymmetrical FDG-PET and MRI findings of striatonigral system in multiple system atrophy with hemiparkinsonism.
Kato T; Kume A; Ito K; Tadokoro M; Takahashi A; Sakuma S
Radiat Med; 1992; 10(3):87-93. PubMed ID: 1509106
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and MRI correlation in multiple system atrophy].
Negoro K; Morimatsu M
No To Shinkei; 1994 May; 46(5):473-8. PubMed ID: 8060686
[TBL] [Abstract][Full Text] [Related]
3. [High-field MR findings of multiple system atrophy].
Tsuchiya K
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jul; 50(7):772-9. PubMed ID: 2235325
[TBL] [Abstract][Full Text] [Related]
4. [Magnetic resonance imaging in multiple system atrophy].
Aotsuka A; Shinotoh H; Hirayama K; Ikehira H; Hashimoto T
Rinsho Shinkeigaku; 1992 Aug; 32(8):815-21. PubMed ID: 1490308
[TBL] [Abstract][Full Text] [Related]
5. Hemi-parkinsonism in multiple system atrophy: a PET and MRI study.
Kume A; Shiratori M; Takahashi A; Kato T; Ito K; Tadokoro M; Sakuma S
J Neurol Sci; 1992 Jul; 110(1-2):37-45. PubMed ID: 1506867
[TBL] [Abstract][Full Text] [Related]
6. A study of parkinsonism in multiple system atrophy: clinical and MRI correlation.
Wakai M; Kume A; Takahashi A; Ando T; Hashizume Y
Acta Neurol Scand; 1994 Oct; 90(4):225-31. PubMed ID: 7839806
[TBL] [Abstract][Full Text] [Related]
7. Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.
Perani D; Bressi S; Testa D; Grassi F; Cortelli P; Gentrini S; Savoiardo M; Caraceni T; Fazio F
Arch Neurol; 1995 Feb; 52(2):179-85. PubMed ID: 7848128
[TBL] [Abstract][Full Text] [Related]
8. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.
Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
J Neurol Sci; 1996 Dec; 144(1-2):77-83. PubMed ID: 8994107
[TBL] [Abstract][Full Text] [Related]
9. Multiple system atrophy. Clinical and MR observations on 42 cases.
Testa D; Savoiardo M; Fetoni V; Strada L; Palazzini E; Bertulezzi G; Girotti F
Ital J Neurol Sci; 1993 Apr; 14(3):211-6. PubMed ID: 8314674
[TBL] [Abstract][Full Text] [Related]
10. Speech disorders in olivopontocerebellar atrophy correlate with positron emission tomography findings.
Kluin KJ; Gilman S; Markel DS; Koeppe RA; Rosenthal G; Junck L
Ann Neurol; 1988 Jun; 23(6):547-54. PubMed ID: 3261572
[TBL] [Abstract][Full Text] [Related]
11. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
[TBL] [Abstract][Full Text] [Related]
12. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy.
Gilman S; Koeppe RA; Junck L; Kluin KJ; Lohman M; St Laurent RT
Ann Neurol; 1994 Aug; 36(2):166-75. PubMed ID: 8053652
[TBL] [Abstract][Full Text] [Related]
13. Multiple system atrophy: a review of 203 pathologically proven cases.
Wenning GK; Tison F; Ben Shlomo Y; Daniel SE; Quinn NP
Mov Disord; 1997 Mar; 12(2):133-47. PubMed ID: 9087971
[TBL] [Abstract][Full Text] [Related]
14. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography.
Yoon RG; Kim SJ; Kim HS; Choi CG; Kim JS; Oh J; Chung SJ; Lee CS
Neurosci Lett; 2015 Jan; 584():296-301. PubMed ID: 25450142
[TBL] [Abstract][Full Text] [Related]
15. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
Lyoo CH; Jeong Y; Ryu YH; Lee SY; Song TJ; Lee JH; Rinne JO; Lee MS
Brain; 2008 Feb; 131(Pt 2):438-46. PubMed ID: 18178568
[TBL] [Abstract][Full Text] [Related]
16. Multiple system atrophy (Shy-Drager syndrome): MR imaging.
Pastakia B; Polinsky R; Di Chiro G; Simmons JT; Brown R; Wener L
Radiology; 1986 May; 159(2):499-502. PubMed ID: 3961183
[TBL] [Abstract][Full Text] [Related]
17. [Multiple system atrophy (MSA)].
Moriwaka F; Tashiro K
Nihon Rinsho; 1993 Nov; 51(11):2952-6. PubMed ID: 8277576
[TBL] [Abstract][Full Text] [Related]
18. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
Otsuka M; Kuwabara Y; Ichiya Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Kato M; Masuda K
Ann Nucl Med; 1997 Aug; 11(3):251-7. PubMed ID: 9310175
[TBL] [Abstract][Full Text] [Related]
19. Neuronal cell loss of the striatonigral system in multiple system atrophy.
Kume A; Takahashi A; Hashizume Y
J Neurol Sci; 1993 Jul; 117(1-2):33-40. PubMed ID: 8410064
[TBL] [Abstract][Full Text] [Related]
20. Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy.
Stocchi F; Carbone A; Inghilleri M; Monge A; Ruggieri S; Berardelli A; Manfredi M
J Neurol Neurosurg Psychiatry; 1997 May; 62(5):507-11. PubMed ID: 9153611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
